Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2002
11/27/2002EP1259604A1 Bcmp 84, a protein associated to breast cancer
11/27/2002EP1259603A2 Antisense oligonucleotides of the human chk1 gene and uses thereof
11/27/2002EP1259601A2 Chimeric and tcr phage display libraries, chimeric and tcr reagents and methods of use thereof
11/27/2002EP1259598A2 Stimulation of cartilage growth with agonists of the non-proteolytically activated thrombin receptor
11/27/2002EP1259595A2 Integrin antagonists
11/27/2002EP1259547A2 High potency recombinant antibodies and method for producing them
11/27/2002EP1259546A1 Ccr2-64i, polymorphic variant of the human ccr2 receptor and its use in the diagnostic and treatment of atherosclerosis
11/27/2002EP1259545A2 Small cell lung cancer associated antigens and uses therefor
11/27/2002EP1259544A2 Heterologous polypeptide of the tnf family
11/27/2002EP1259541A2 Amino acid sequences facilitating penetration of a substance of interest into cells and/or cell nuclei
11/27/2002EP1259540A1 Nucleic acids, proteins, and antibodies
11/27/2002EP1259538A2 Proteins and nucleic acids encoding the same
11/27/2002EP1259536A2 Methods of peptide preparation
11/27/2002EP1259535A1 Cyclic hexapeptide derivatives
11/27/2002EP1259531A2 Nucleic acids, proteins, and antibodies
11/27/2002EP1259527A1 35 human secreted proteins
11/27/2002EP1259526A2 Nucleic acids, proteins, and antibodies
11/27/2002EP1259525A1 Serine/threonine phosphatase polynucleotides, polypeptides, and antibodies
11/27/2002EP1259269A1 Agent for the treatment of wounds
11/27/2002EP1259265A2 Nucleic acid formulations for gene delivery and methods of use
11/27/2002EP1259255A1 Pai-2 conjugates for the treatment and imaging of cancer
11/27/2002EP1259254A1 Method of treatment of anorectal disorders
11/27/2002EP1259253A2 Methods for promoting production of myelin by schwann cells
11/27/2002EP1259252A2 Soluble tumor necrosis factor receptor and il-4 inhibitor for the treatment of medical disorders
11/27/2002EP1259251A2 Novel method for down-regulation of amyloid
11/27/2002EP1259250A1 Endoparasiticidal agents
11/27/2002EP1259248A1 Methods for treating, screening for, and detecting cancers expressing vascular endothelial growth factor d
11/27/2002EP1259247A1 DNA ENCODING HUMAN ACID-SENSING ION CHANNEL BNaC4 (ASIC4)
11/27/2002EP1259246A2 Use of dpp-iv inhibitors for the treatment of diabetes
11/27/2002EP1259228A1 Therapeutic compositions for pulmonary delivery
11/27/2002EP1259222A1 Novel use of pulmonary surfactant for the prophylaxis and treatment of chronic pulmonary diseases
11/27/2002EP1259120A2 Method for isolating sponge collagen and producing nanoparticulate collagen, and the use thereof
11/27/2002EP1259112A1 Nutritional intervention composition for enhancing and extending satiety
11/27/2002EP1246649A4 Intravascular delivery of nucleic acid
11/27/2002EP1180164A4 Methods using of fab i and compounds modulating fab i activity
11/27/2002EP1083929A4 The use of anabolic agents, anti-catabolic agents, antioxidant agents, and analgesics for protection, treatment and repair of connective tissues in humans and animals
11/27/2002EP1059931B1 Utilization of cd137 in order to promote the proliferation of peripheral monocytes
11/27/2002EP0994887B1 Modified glycosides, compositions comprised thereof and methods of use thereof
11/27/2002EP0920330B1 hCG AND DERIVATIVES AS MATRIX METALLOPROTEASES INHIBITORS
11/27/2002EP0871649B1 Conjugates of a polypeptide and a biocompatible polymer
11/27/2002EP0783316B1 Antifungal and antibiotic synthetic peptides
11/27/2002EP0776331B1 Higher order structure and binding of peptide nucleic acids
11/27/2002EP0726907B1 Process for producing a virus-inactivated factor viii-containing fraction by chromatographic methods
11/27/2002EP0700402B1 Methods and materials for modulation of the immunosuppressive activity and toxicity of monoclonal antibodies
11/27/2002EP0675961B1 Treatment of tumorigenic disease with a modified HSV
11/27/2002EP0671928B1 Synthesis of n-substituted oligomers
11/27/2002EP0644896B1 PEPTIDES REPRESENTING ANTIGENIC EPITOPES OF IgE PRESENT ON B CELL BUT NOT BASOPHIL SURFACE
11/27/2002EP0627933B1 Bystander suppression of autoimmune diseases
11/27/2002EP0608261B1 Immunoreactive hepatitis c virus polypeptide compositions
11/27/2002CN1382216A DNA coding for beta-tubulin and use thereof
11/27/2002CN1382214A Novel protein derived from agkistrodon saxatilis emelianov and process for preparing the same
11/27/2002CN1382211A Treatment of inflammatory or malignant disease using dnazymes
11/27/2002CN1382158A Multiple cytokine-antibody complexes
11/27/2002CN1382157A Therapeutic compounds comprised of anti-FC receptor binding agents
11/27/2002CN1382156A PABLO polypeptide that interacts with BCL-XL and uses related thereto
11/27/2002CN1382154A Basic monocyclic compounds having NK2 antagonist action processes for their preparation and formulations containing them
11/27/2002CN1382150A Hydromycin derivatives
11/27/2002CN1382119A Substituted alpha hydroxy acid aspertate specific cysteine protease inhibitors and use thereof
11/27/2002CN1382061A Pharmaceutical compositions for oral and topical administration
11/27/2002CN1382060A Dosages for treatment with anti-ErbB2 antibodies
11/27/2002CN1382059A Method and compositions for prevneting or reducing HIV infection
11/27/2002CN1382058A Method to enhance healing of sternum after sternotomy
11/27/2002CN1382057A Treatment of conjunctivitis
11/27/2002CN1382053A Novel hormonal composition and use thereof
11/27/2002CN1382047A Neurotherapeutic clavulanate composition and method
11/27/2002CN1381580A Polypeptide-human topoisomerase -13.64 and polynucleotide for coding it
11/27/2002CN1381579A Polypeptide-guanylyl cyclase-13.53 and polynucleotide for coding it
11/27/2002CN1381578A Polypeptide-human protein orginine deimidase-76.34 and polynucleotide for coding it
11/27/2002CN1381577A Polypeptide-human glycohydrolase-12.98 and polynucleotide for coding it
11/27/2002CN1381576A Polypeptide-fructose-1,6-diphosphase-15.51 and polynucleotide for coding it
11/27/2002CN1381575A Polypeptide-human receptor associated protein tyrosine phosphatase -16.94 and polynucleotide for coding it
11/27/2002CN1381573A Polypeptide-diphosphate adenoribosomal diphoisphatase-38.5 and polynucelotide for coding it
11/27/2002CN1381572A Polypeptide-adenylate kinase-9.79 and polynucleotid for coding it
11/27/2002CN1381571A Polypeptide-human signal transducer kinase-22.55 and polynucleotide for coding it
11/27/2002CN1381570A Polypeptide-phosphoribulokinase-10.78 and polynucleotide for coding it
11/27/2002CN1381568A Polypeptide-human glutathione transferase -26.73 and polynuceotide for coding it
11/27/2002CN1381567A Polypeptide-serine hydroxymethyl transferase-10.56 and polynucleotide for coding it
11/27/2002CN1381566A Polypeptide-hydroxymethyl glutaryl CoA reductase-9.35 and polynucleotide for coding it
11/27/2002CN1381565A Polypeptide-respiratory chain dehydrogenase-11.55 and polynucleotide for coding it
11/27/2002CN1381564A Polypeptide-human phosphate synthetase-11.55 and polynucleotide for coding it
11/27/2002CN1381562A Antigen-sensitive human GM-CSF gene modified human dendritic cell and its preparing process and usage
11/27/2002CN1381512A Multi-arm fork type functional polyethylene glycol preparation method and its application in medicine
11/27/2002CN1381501A Tumor necrosis factor inhibiting peptide and its application
11/27/2002CN1381460A Structure and usage of plasminogen activator (TPA) mutant
11/27/2002CN1381273A Vaginal-applied interferon table and its preparing process
11/27/2002CN1381272A Application of insulinotropic peptide GLP-1 (7-36) and its solt
11/27/2002CN1381271A Application of insulinotropic peptide Exendin 4 analog and its salt
11/27/2002CN1381270A Ca-supplementing instant composite polypeptide powder and its preparing process
11/27/2002CN1094943C Urethanes and ureas that induce cytokine production
11/27/2002CN1094931C Antithrombotic organic nitrates
11/26/2002US6486311 Peanut allergens and methods
11/26/2002US6486305 Method of modulating the efficiency of translation termination and degradation of aberrant mrna involving a surveillance complex comprising human upf1p, eucaryotic release factor 1 and eucaryotic release factor 3
11/26/2002US6486301 Interleukin-20
11/26/2002US6486300 Human nm23-like protein
11/26/2002US6486299 Genes and proteins predictive and therapeutic for stroke, hypertension, diabetes and obesity
11/26/2002US6486193 Antiarthritic agents; antiinflammatory agents
11/26/2002US6486181 Human leukocutye 12-lipoxygenase and its role in the pathogenesis of disease states
11/26/2002US6486138 Ophthalmic compositions containing galactomannan polymers and borate
11/26/2002US6486134 Administering exogenous genes
11/26/2002US6486133 Methods for inducing localized vascular development and enhancing the repair of a wound in the mammamian dermis
1 ... 1950 1951 1952 1953 1954 1955 1956 1957 1958 1959 1960 1961 1962 1963 1964 1965 1966 1967 1968 1969 1970 ... 3163